GeoPharma, Inc. · Largo, FL United States (Pink Sheets: GORX)
Key GeoPharma, Inc. Financials
| Company Type | Public -(Pink Sheets: GORX) Headquarters |
|---|---|
| Fiscal Year-End | March |
| 2004 Sales (mil.) | $23.0 |
| Employees | 271 |
GeoPharma, Inc. Stock Quote (Pink Sheets: GORX)
| Latest 03/25/11 15:29:31 EST | Change ($) | Change (%) | High | Low |
|---|---|---|---|---|
| $0.03 | 0.000 | 0.000 | $0.00 | $0.00 |
Quotes delayed 15 minutes for NASDAQ, 20 minues for NYSE and AMEX. Market Data provided by Interactive Data. Powered and Implemented by Interactive Data Managed Solutions. |
GeoPharma, Inc. Income Statement
| Mar 04 | Mar 03 | Mar 02 | |
| Revenue | 23.0 | 14.7 | 9.0 |
| Cost of Goods Sold | 17.0 | 10.7 | 7.0 |
| Gross Profit | 6.0 | 4.0 | 2.0 |
| Gross Profit Margin | 25.9% | 27.3% | 22.1% |
| SG&A Expense | 4.3 | 3.7 | 3.2 |
| Depreciation & Amortization | 0.4 | 0.4 | 0.4 |
| Operating Income | 1.2 | 0.4 | (1.2) |
| Operating Margin | 5.2% | 2.4% | -13.3% |
| Nonoperating Income | 0.4 | 0.7 | 0.1 |
| Nonoperating Expenses | -- | -- | -- |
| Income Before Taxes | 1.4 | 1.0 | (1.1) |
| Income Taxes | 0.3 | (0.1) | -- |
| Net Income After Taxes | 1.1 | 1.2 | (1.1) |
| Continuing Operations | 1.1 | 1.2 | (1.1) |
| Discontinued Operations | -- | -- | -- |
| Total Operations | 1.1 | 1.2 | (1.1) |
| Total Net Income | 1.1 | 1.2 | (1.1) |
| Net Profit Margin | 4.9% | 7.8% | -12.5% |
| Diluted EPS from Total Net Income | 0.11 | 0.15 | (0.16) |
| Dividends per Share | -- | -- | -- |
All amounts in millions of US Dollars except per share amounts.
GeoPharma, Inc. Balance Sheet
| Assets | Mar 04 | Mar 03 | Mar 02 |
| Current Assets | |||
| Cash | 8.4 | 0.5 | 0.4 |
| Net Receivables | 3.2 | 1.8 | 1.7 |
| Inventories | 3.2 | 2.1 | 2.1 |
| Other Current Assets | 5.8 | 1.1 | 1.3 |
| Total Current Assets | 20.6 | 5.5 | 5.5 |
| Net Fixed Assets | 1.8 | 1.5 | 1.6 |
| Other Noncurrent Assets | 1.3 | 1.1 | 1.1 |
| Total Assets | 23.8 | 8.1 | 8.2 |
| Liabilities | Mar 04 | Mar 03 | Mar 02 |
| Current Liabilities | |||
| Accounts Payable | 2.1 | 0.9 | 1.4 |
| Short-Term Debt | 1.5 | 1.2 | 0.9 |
| Other Current Liabilities | 0.7 | 0.7 | 0.7 |
| Total Current Liabilities | 4.3 | 2.8 | 3.0 |
| Long-Term Debt | 2.8 | 0.2 | 0.4 |
| Other Noncurrent Liabilities | 0.0 | 0.5 | 1.2 |
| Total Liabilities | 7.1 | 3.5 | 4.6 |
| Shareholder's Equity | |||
| Preferred Stock Equity | 0.1 | -- | -- |
| Common Stock Equity | 16.6 | 4.6 | 3.7 |
| Total Equity | 16.7 | 4.6 | 3.7 |
| Shares Outstanding (thou.) | 23,398.8 | 23,398.8 | 23,398.8 |
All amounts in millions of US Dollars except per share amounts.
GeoPharma, Inc. Cash Flow Statement
| Mar 04 | Mar 03 | Mar 02 | |
| Net Operating Cash Flow | 0 | 1 | (2) |
| Net Investing Cash Flow | (0.8) | (0.3) | (0.9) |
| Net Financing Cash Flow | 13.0 | (0.8) | (0.3) |
| Net Change in Cash | 12.7 | 0.1 | (2.9) |
| Depreciation & Amortization | 0.4 | 0.4 | 0.4 |
| Capital Expenditures | (0.8) | (0.4) | (0.9) |
| Cash Dividends Paid | (0.1) | (0.1) | (0.2) |
All amounts in millions of US Dollars except per share amounts.